These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34246677)

  • 1. A prokaryote system optimization for rMEPLox expression: A promising non-toxic antigen for Loxosceles antivenom production.
    Saavedra-Langer R; Costa TGF; Lima SA; Costal-Oliveira F; Martins CA; Machado-de-Ávila RA; Minozzo JC; Soccol VT; Guerra-Duarte C; Kalapothakis E; Chávez-Olórtegui C
    Int J Biol Macromol; 2021 Sep; 187():66-75. PubMed ID: 34246677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Protein Containing B-Cell Epitopes of Different
    Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Front Immunol; 2018; 9():653. PubMed ID: 29666624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered antigen containing epitopes from Loxosceles spp. spider toxins induces a monoclonal antibody (Lox-mAb3) against astacin-like metalloproteases.
    Costa TGF; Costal-Oliveira F; de Assis TCS; Lima SA; Martins CA; Finco AB; Veiga SS; Soccol VT; Machado-de-Ávila RA; Figueiredo LFM; Minozzo JC; Kalapothakis E; Guerra-Duarte C; Alvarenga LM; Chávez-Olórtegui C
    Int J Biol Macromol; 2020 Nov; 162():490-500. PubMed ID: 32574737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial in vivo protection against Peruvian spider Loxosceles laeta venom by immunization with a multiepitopic protein (rMEPLox).
    Quispe RL; Jaramillo ML; Torres-Huaco F; Bonilla C; Isasi J; Guerra-Duarte C; Chávez-Olórtegui C
    Toxicon; 2022 Aug; 215():1-5. PubMed ID: 35660625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
    de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
    J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
    Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
    Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
    Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
    Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies Against
    Calabria PAL; Shimokava-Falcao LHAL; Colombini M; Moura-da-Silva AM; Barbaro KC; Faquim-Mauro EL; Magalhaes GS
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30759862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immunological cross-reactivity of LALP3, a novel astacin-like metalloprotease from brown spider (Loxosceles intermedia) venom.
    Morgon AM; Belisario-Ferrari MR; Trevisan-Silva D; Meissner GO; Vuitika L; Marin B; Tashima AK; Gremski LH; Gremski W; Senff-Ribeiro A; Veiga SS; Chaim OM
    Biochimie; 2016; 128-129():8-19. PubMed ID: 27343628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.
    Karim-Silva S; Moura Jd; Noiray M; Minozzo JC; Aubrey N; Alvarenga LM; Billiald P
    Immunol Lett; 2016 Aug; 176():90-6. PubMed ID: 27288291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens.
    Olvera A; Ramos-Cerrillo B; Estévez J; Clement H; de Roodt A; Paniagua-Solís J; Vázquez H; Zavaleta A; Arruz MS; Stock RP; Alagón A
    Toxicon; 2006 Jul; 48(1):64-74. PubMed ID: 16759681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands.
    Tambourgi DV; de F Fernandes Pedrosa M; van den Berg CW; Gonçalves-de-Andrade RM; Ferracini M; Paixão-Cavalcante D; Morgan BP; Rushmere NK
    Mol Immunol; 2004 Jul; 41(8):831-40. PubMed ID: 15234562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders.
    Souza NA; Dias-Lopes C; Matoso ÍHG; de Oliveira CFB; Chávez-Olortegui CD; Minozzo JC; Felicori LF
    Vaccine; 2018 Nov; 36(48):7324-7330. PubMed ID: 30352745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
    Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
    Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brown spider (Loxosceles genus) venom toxins: Evaluation of biological conservation by immune cross-reactivity.
    Buch DR; Souza FN; Meissner GO; Morgon AM; Gremski LH; Ferrer VP; Trevisan-Silva D; Matsubara FH; Boia-Ferreira M; Sade YB; Chaves-Moreira D; Gremski W; Veiga SS; Chaim OM; Senff-Ribeiro A
    Toxicon; 2015 Dec; 108():154-66. PubMed ID: 26474948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
    Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
    Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
    de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
    Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History, challenges and perspectives on Loxosceles (brown spiders) antivenom production in Brazil.
    Miranda ALS; Guerra-Duarte C; Lima SA; Chávez-Olórtegui C; Soto-Blanco B
    Toxicon; 2021 Mar; 192():40-45. PubMed ID: 33465358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Effects of the Immunization Protocol Using
    Miranda ALS; Antunes BC; Minozzo JC; Lima SA; Botelho AFM; Campos MTG; Chávez-Olórtegui CD; Soto-Blanco B
    Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.